Stefanie Parisien-La Salle
Overview
Explore the profile of Stefanie Parisien-La Salle including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
47
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Parisien-La Salle S, Brown J, Mahrokhian S, Hanna I, Honzel B, Tsai L, et al.
J Clin Endocrinol Metab
. 2025 Mar;
PMID: 40036317
Background: A continuum of non-suppressible aldosterone production has been demonstrated in normotensive individuals, termed subclinical primary aldosteronism (PA), and is consistently associated with increased risk for developing hypertension and cardiovascular...
2.
Parisien-La Salle S, Perreault F, Corbeil G, Morisset J, Poirier C, Beauregard C, et al.
Front Endocrinol (Lausanne)
. 2025 Feb;
15:1481906.
PMID: 39981138
Background: Pheochromocytomas (PCCs) and paragangliomas (PGLs) (PPGLs) are rare tumours arising from the chromaffin cells. There is evidence suggesting a link between hypoxemia and PPGLs. Chronic hypoxia can lead to...
3.
Parisien-La Salle S, Bourdeau I
J Endocr Soc
. 2024 Feb;
8(3):bvae005.
PMID: 38313160
Context: Biological sex can play a role in the severity of certain diseases. Objective: Our objective was to evaluate whether sex-related differences affect the signs and symptoms of pheochromocytomas and...
4.
Parisien-La Salle S, Corbeil G, El-Haffaf Z, Duranceau C, Latour M, Karakiewicz P, et al.
J Clin Endocrinol Metab
. 2022 Sep;
108(1):26-32.
PMID: 36179244
Background: Adrenal tumors are found in up to 40% of patients with multiple endocrine neoplasia type 1 (MEN1). However, adrenocortical carcinomas (ACC) and primary aldosteronism (PA) are rare in MEN1....
5.
Parisien-La Salle S, Chbat J, Lacroix A, Perrotte P, Karakiewicz P, Saliba I, et al.
Cancers (Basel)
. 2022 Jun;
14(12).
PMID: 35740606
At least 10% of pheochromocytomas (PHEOs) and paragangliomas (PGLs) (PPGLs) may recur after the initial surgery. Guidelines recommend annual screening for recurrence in non-metastatic tumors for at least 10 years...
6.
Parisien-La Salle S, Dumas N, Bedard K, Jolin J, Moramarco J, Lacroix A, et al.
Clin Endocrinol (Oxf)
. 2021 Nov;
96(6):803-811.
PMID: 34750850
Objective: Pheochromocytomas (PHEOs) and paragangliomas (PGLs), collectively known as PPGLs, are tumours with high heritability. The prevalence of germline mutations in apparently sporadic PPGLs varies depending on the study population....
7.
Parisien-La Salle S, Provencal M, Bourdeau I
Endocr Pract
. 2021 Feb;
27(4):318-325.
PMID: 33581325
Objective: To evaluate the usefulness of chromogranin A (CgA) in the management of patients with pheochromocytomas (PHEOs) and paragangliomas (PGLs). Methods: We retrospectively reviewed the charts of 132 patients with...
8.
Bourdeau I, Parisien-La Salle S, Lacroix A
Best Pract Res Clin Endocrinol Metab
. 2020 Mar;
34(3):101386.
PMID: 32115357
Adrenocortical hyperplasia may develop in different contexts. Primary adrenal hyperplasia may be secondary to primary bilateral macronodular adrenocortical hyperplasia (PBMAH) or micronodular bilateral adrenal hyperplasia (MiBAH) which may be divided...
9.
Parisien-La Salle S, Dumas N, Rondeau G, Latour M, Bourdeau I
Front Endocrinol (Lausanne)
. 2019 Sep;
10:546.
PMID: 31551924
Pheochromocytomas (PHEOs) are a rare cause of endocrine hypertension that requires genetic counseling since at least 30% of PHEOs are associated with a germline mutation in a susceptibility gene. Neurofibromatosis...
10.
Parisien-La Salle S, Abel Rivest E, Boucher V, Lalande-Gauthier M, Morisset J, Manganas H, et al.
J Cardiopulm Rehabil Prev
. 2019 Jan;
39(2):112-117.
PMID: 30624373
Background: Although mainly described in patients with chronic obstructive pulmonary disease, pursed lip breathing (PLB) could prove useful in patients with interstitial lung disease (ILD) by improving exertional tachypnea and...